Malian government to reimburse GAVI Alliance for grant money after joint investigation shows misuse

NewsGuard 100/100 Score

The GAVI Alliance on Thursday said an investigation conducted by a GAVI transparency and accountability team and auditors from the Malian government "has found that $563,000 was misused in two of its cash-based projects in Mali, and Malian authorities have agreed to pay it back," Reuters reports. The Malian government arrested four individuals in connection with the misuse of the funds, and during the investigation, GAVI suspended $1.8 million in unused funds, the news service adds (Kelland, 5/19).

"Sixty percent of the misused amount, or $335,000, was judged by investigators as ineligible expenses, which although used in the health sector, were outside the scope of GAVI's funding agreement. The remaining 40% of the funds, $228,000, were spent on nonexistent activities or on fictitious procurement of goods and services," a GAVI press release states (5/19).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.